US PTAB IP Litigation

Jeisys Medical Inc. et al. v.Serendia, LLC

Serendia requests the USPTO Director to vacate the institution of an IPR against its dermatology device patent after the ITC upheld the patent’s validity, arguing the Board abused discretion and that the Fintiv factors favor denial.

Jeisys Medical Inc. et al. v.Serendia, LLC

patent terminated or settled · Sep 1, 2024

EndyMed Medical and Serendia have settled their IPR dispute over U.S. Patent 9,775,774. The parties jointly filed a motion requesting the Board terminate the proceeding before any oral hearing.

Jeisys Medical Inc. et al. v.Serendia, LLC

The PTAB granted a settlement‑based termination for Jeisys Medical in three IPRs while allowing the proceedings to continue for EndyMed. The settlement agreement was ordered to be kept confidential.

Jeisys Medical Inc. et al. v.Serendia, LLC

Jeisys Medical and Serendia have filed a joint request in IPR2024-00383 to keep their settlement agreement confidential under 35 U.S.C. § 317(b). The parties seek to have the agreement treated as business confidential information and kept separate from the patent file.

Jeisys Medical Inc. et al. v.Serendia, LLC

patent terminated or settled · Sep 1, 2024

During an IPR hearing, Jeisys Medical announced a settlement with SHEnB and Cartessa respondents, seeking to suspend the schedule until November 20.

Jeisys Medical Inc. et al. v.Serendia, LLC

Jeisys Medical and Serendia settled their IPR dispute over U.S. Patent 9,775,774 and jointly moved to terminate the proceeding.

Jeisys Medical Inc. et al. v.Serendia, LLC

patent terminated or settled · Sep 1, 2024

Court decision.

TransCore LP v.Hand Held Products, Inc.

· IPR2024-00391

TransCore and Hand Held Products entered a confidential settlement and jointly moved to terminate IPR2024-00391 concerning U.S. Patent 8,141,784. The Board has not yet decided the merits, and the parties request termination to conserve resources.

Jeisys Medical Inc. et al. v.Serendia, LLC

patent null · Sep 1, 2024

EndyMed Medical and Serendia have filed a joint request to keep their settlement agreement confidential under statutory provisions, separating it from the patent record.

TransCore LP v.Hand Held Products, Inc.

· IPR2024-00391

TransCore LP challenges U.S. Patent No. 8,141,784 in the PTAB, asserting that the claims are unpatentable over prior art references Tolonen and Katz. The petitioner argues that the core features of the patent—such as EIR terminals connecting chipsets to baseband software—are anticipated or obvious based on these older technologies.

patent null · Sep 1, 2024

Jeisys Medical Inc. et al. v.Serendia, LLC

patent instituted · Sep 1, 2024

Jeisys Medical Inc. challenged Serendia, LLC's '774 patent in an IPR petition, asserting that claims are anticipated by Mehta and rendered obvious through combinations involving Na ’848 and Lee. The petition focuses on the unpatentability of medical device claims related to dermatological treatment/microneedling.

Jeisys Medical Inc. et al. v.Serendia, LLC

patent some challenged claims unpatentable · Aug 30, 2024

The PTAB instituted an IPR challenging claims 13 and 14 of Serendia's patent, finding a reasonable likelihood of anticipation by the prior art reference Mehta. The case moves to trial phase after rejecting arguments for discretionary denial based on competitor relationships.

Simpson Strong-Tie Company Inc. et al. v.Columbia Insurance Company et al.

patent mixed - some claims cancelled, some upheld · Aug 30, 2024

The PTAB issued a Final Written Decision in PGR2024‑00050, finding claims 5 and 17 indefinite and lacking written description, and deeming claims 1‑12, 15‑17, and 21‑23 obvious over Gilb ’792 and Bundy. The Board granted a partial amendment for claim 32 while denying other proposed substitute claims.

Simpson Strong-Tie Company Inc. et al. v.Columbia Insurance Company et al.

The PTAB found 103 of the 105 claims of Simpson Strong‑Tie’s fire‑wall hanger patent unpatentable as obvious over a combination of Yamaguchi, Bundy, Adams and Gilb ’416 references. Claims 38 and 91 were left intact. The Board adopted petitioner‑proposed claim constructions.

Simpson Strong-Tie Company Inc. et al. v.Columbia Insurance Company et al.

Simpson Strong‑Tie challenges Columbia Insurance’s post‑grant review of U.S. Patent 11,920,339 covering fire‑wall hanger systems. The patent owner’s sur‑reply argues the petition’s obviousness and written‑description attacks fail, emphasizing strong secondary‑consideration evidence. The case remains pending before the PTAB.

Simpson Strong-Tie Company Inc. et al. v.Columbia Insurance Company et al.

Simpson Strong‑Tie and Columbia Insurance have settled their dispute over U.S. Patent 11,920,339 and jointly filed a request to keep the settlement agreement confidential while moving to terminate the post‑grant review.

Simpson Strong-Tie Company Inc. et al. v.Columbia Insurance Company et al.

Simpson Strong‑Tie and Columbia Insurance have settled their dispute over U.S. Patent 11,920,339 and jointly moved to terminate the post‑grant review. The Board is asked to dismiss the proceeding under its authority to end settled cases.

Simpson Strong-Tie Company Inc. et al. v.Columbia Insurance Company et al.

Simpson Strong‑Tie and Columbia Insurance reached a confidential settlement, prompting the PTAB to terminate the post‑grant review of patent 11,920,339. The Board granted the joint motion to keep the settlement confidential and end the proceeding.

patent denied · Aug 30, 2024

Nikon Corporation et al. v.Optimum Imaging Technologies LLC

· IPR2024-01372

Optimum Imaging Technologies and Fujifilm have reached a settlement-in-principle in their imaging patent dispute, seeking a stay of court deadlines and planning to dismiss the case.

Apple Inc. v.Varia Holdings LLC

· IPR2024-01363

Apple filed a response defending the PTAB’s finding that claims 1‑32 of Varia’s RFID‑enabled mobile device patent are obvious. The company argues the Board correctly relied on intrinsic record and prior art, not on the patent owner’s functional‑emulation arguments.

patent all challenged claims unpatentable · Aug 30, 2024

Apple Inc. v.Varia Holdings LLC

· IPR2024-01362

Apple’s petition argues that the PTAB correctly found Varia’s RFID‑related claims obvious over Willgert‑Mooney, rejecting the patent owner’s construction and a Director Review request. The Board denied the request, leaving all 19 claims unpatentable.

Apple Inc. v.Varia Holdings LLC

· IPR2024-01362

Varia Holdings LLC requests Director Review of a PTAB decision that found Apple’s RFID‑emulation patent claims unpatentable. The owner contends the Board relied on a new, unsupported “functional emulation” theory not raised in the Petition. The request seeks reversal of the unpatentability findings for all 19 claims.

Nikon Corporation et al. v.Optimum Imaging Technologies LLC

· IPR2024-01372

Optimum Imaging Technologies and Olympus have settled their district court case, seeking a 45‑day stay to finalize dismissal.